Background Zoledronic acid-induced uveitis (ZAIU) is rare but severe, and has been
recently considered part of an acute phase reaction. Only 15 cases have been reported …

This prospective study showed that the incidence of acute anterior uveitis, confirmed by
ophthalmic examination, in patients receiving intravenous zoledronate infusions as part of a …

Bisphosphonates are used to inhibit bone absorption as a treatment for hypercalcemia
associated with osteolytic bone cancer, bony metastasis, Paget disease, and osteoporosis …

old man was diagnosed as having advanced prostate cancer in November 1997. Bony
metastases were found in the thoracic spine and ribs, and the patient underwent external …

With the increased use of nitrogen bisphosphonate therapy for osteoporosis, multiple
myeloma, metastatic prostate carcinoma, and Paget disease, it is now recognized that orbital …

PURPOSE: To report recent ocular adverse drug reactions identified by the National
Registry of Drug-Induced Ocular Side Effects. METHODS: Case reports from the National …

Cutaneous adverse reactions are reported for many treatments including antiosteoporotic
agents. This position paper includes an algorithm for their recognition. With early recognition …

A 60-year-old woman received a single 5-mg dose of zoledronic acid (Aclasta®) for
treatment of postmenopausal osteoporosis. One day after receiving the drug, she acutely …

Ocular adverse effects of pamidronic acid are rare but well documented. Pamidronate, an
inhibitor of bone resorption used primarily in the management of tumor-induced …

Objective To identify risk factors involved in the development of idiopathic orbital
inflammation (IOI). Methods Case–control study of 69 adults who had had a first episode of …